ALK
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · Denmark · 1K - 5K Employees
View Company Info for Free
Overview
Headquarters
Bøge Allé 6-8, Korsholm, North Denmark, ...Phone Number
+45 45747576Website
www.alk.netRevenue
$955.8 MillionStock Symbol
ALK-BIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About ALK
ALK-Abelló is a global pharmaceutical company specializing in allergy immunotherapy treatments and diagnostics. Based in Denmark, the company develops, manufactures, and markets allergy vaccines and diagnostic products for the prevention and treatment of allergies. ALK focuses on sublingual and subcutaneous immunotherapy solutions that address respiratory allergies, including pollen, dust mites, and other allergens. The company is dedicated to improving the lives of people with allergies through innovative treatment approaches, working closely with healthcare professionals to provide evidence-based allergy care solutions worldwide.Explore more
ALK Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is ALK your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
ALK, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at ALK
Product Launch: Get notified when ALK launches new products
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if ALK had a recent Job posting/layoffs
Earning: See what the market has to say on ALK recently announced quarterly report
Check out if ALK is spiking on competitors!
Check if ALK has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once ALK has new funding data
Recommended Actions
Find VP level buyers at ALK
Find more new buyers
Company Profile Activity
Activity Insights
ALK is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
ALK is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about ALK.
ALK Tech Stack
A closer look at the technologies used by ALK
See more technologies
Most Recent Scoops
Hiring Plans
ALK has more open roles in Operations than it has had at any time in the past 12 months. Technologies mentioned include: SAP.
Hiring Plans
Open Position
Open Position
Open Position
Open Position
ALK News & Media
Alaska Air Group, Inc. (ALK) Q2 2026 Earnings Call Transcript
Alaska Air Group, Inc. (ALK) Q2 2026 Earnings Call July 22, 2026 11:30 AM EDTCompany ParticipantsRyan St.Former R&D chief at ALK joins Leo Foundation's board of directors - MedWatch
In addition to her three years as head of research at ALK, Henriette Mersebach has also previously held a number of leadership positions at Novo Nordisk.EURneffy 1 mg approved in the UK as the first and only needle-free adrenaline treatment for young children (aged 4 and older, 15–30 kg) at risk of anaphylaxis
ALK announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorisation for EURneffy® 1 mg, the first and only needle-free adrenaline treatment for anaphylaxis for children aged 4 and older living with severe allergies in the UK – extending a class of treatment previously available only by injection.Anaphylaxis management is falling short in 2026 – EAACI data suggest EURneffy, the only needle-free nasal adrenaline spray, could help close the gap
New scientific data reveal serious shortcomings in the real-world management of anaphylaxis, with findings from two multi-country surveys suggesting that EURneffy®—the first and only approved needle-free adrenaline-based product—may help address some of the practical and psychological challenges that limit effective emergency treatment in daily life.1,2 The data generated by ALK were presented at the 2026 European Academy of Allergy and Clinical Immunology (EAACI) Annual Congress in Istanbul, Tu
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding ALK
Sign Up For FreeTo access detailed company insights
ALK-Abelló is a global pharmaceutical company specializing in allergy immunotherapy treatments and diagnostics. Based in Denmark, the company develops, manufactures, and markets allergy vaccines and diagnostic products for the prevention and treatment of allergies. ALK focuses on sublingual and subcutaneous immunotherapy solutions that address resp... Read More
